Trial Details
COMPLETEDBasic Information
| Clinical ID | c803 |
|---|---|
| Identifier | NCT06027229 |
| Trial Title | Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Immunosuppression|COVID-19 |
| Interventions | BIOLOGICAL: NVX-CoV2372 |
Participant Information
| Sponsor | University of Wisconsin, Madison |
|---|---|
| City | Madison |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-11-20 |
|---|---|
| Primary Completion Date | 2024-04-24 |
| Completion Date | 2024-09-09 |